These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 9629854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA, Koblar S, Hughes RA.
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antiganglioside antibodies: when, which and for what].
    Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I.
    Neurologia; 2001 Feb; 16(7):293-7. PubMed ID: 11485721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N, Yoshino H, Sato S, Ohno T, Miyatake T.
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [Abstract] [Full Text] [Related]

  • 10. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y, Matsumoto Y, Yuki N.
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM.
    Ann Biol Clin (Paris); 1999 Sep; 57(5):579-88. PubMed ID: 10518060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L, Casellato R, Ciampa MG, Uekusa Y, Kato K, Kaida K, Motoyama M, Kusunoki S, Sonnino S.
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N.
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [Abstract] [Full Text] [Related]

  • 19. Generation of murine monoclonal antibodies specific for N-glycolylneuraminic acid-containing gangliosides.
    Ozawa H, Kawashima I, Tai T.
    Arch Biochem Biophys; 1992 May 01; 294(2):427-33. PubMed ID: 1567198
    [Abstract] [Full Text] [Related]

  • 20. Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies.
    Yuki N, Miyagi F.
    J Neurol Sci; 1996 Jul 01; 139(1):160-2. PubMed ID: 8836989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.